Pender HPM-Based Online Education and Telephone Follow-Up in Adults With Heart Failure

StatusCompleted
PhaseNot applicable
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary endpoints revised (3) Show 4 more changesShow less
    • Interventions: Heart failure medication (Other) to HPM-Based Online Education and Telephone Follow-Up (Other)
    • Eligibility criteria expanded, about 59 words
    • Study description shortened, about 470 words
    • Study title revised
  2. Start date changed from estimate of Jul 15, 2025 to Dec 20, 2025 Show 5 more changesShow less
    • Completed without a posted recruiting period
    • Primary completion date changed from estimate of Sep 15, 2025 to Feb 15, 2026
    • Study completion date changed from estimate of Dec 30, 2025 to Mar 30, 2026
    • Eligibility criteria expanded, about 7 words
    • Study description expanded, about 9 words
  3. Study title shortened, about 6 wordsv2
  4. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Naile ALANKAYA
3 trials monitored
See all monitored trials
Heart Disease
8,814 trials monitored
See 428 trials at risk
Heart Failure
2,000 trials monitored
See 115 trials at risk
This randomized controlled trial evaluated the effects of Pender's Health Promotion Model (HPM)-based structured online education combined with planned telephone follow-up on heart failure symptom burden, heart failure-related dietary behaviors, and medication adherence among adults with heart failure. Sixty participants were randomly allocated in a 1:1 ratio to an intervention group or a control group. The intervention group received routine clinical care plus individualized synchronous online education and two planned telephone reinforcement contacts, whereas the control group received routine clinical care. The three primary outcomes were assessed at baseline and 2 months after baseline.
Trial Details
NCT Number NCT07017751
Lead Sponsor Naile ALANKAYA
Conditions
(from sponsor)		 Heart Failure
Related terms Heart Failure, Medication Adherence
Enrollment 60 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov